H1N1 vaccine recall: CDC pulls almost one million doses off the market

FB Share

Just when you thought you'd gathered all the information you needed to make an educated decision about the H1N1 vaccine, the CDC drops a bombshell and recalls close to one million doses.   It's important to note that this is a "non-safety-related volunatary recall, meaning the medicine is not being pulled for doing harm but rather, in this case, for not doing enough good.  It turns out that in recent "stability tests" of the medication produced by Sanofi Pasteur, the drug's potency in the pre-filled pediatric syringes that had been distributed had dropped below pre-specified limits.  Bottom line: in four lots tested, the vaccine wasn't strong enough.  

No doubt, this is going to fuel the fires of the "to vaccinate or not to vaccinate" debate, giving both sides an opportunity to come out swinging.   But before you jump to any conclusions, make sure you check out the FAQ on the CDC website.  They've anticipated a lot of worried parents' questions and have answers at the ready.

More from Parents Ask

Swine flu vaccine: Dangerous or safe?

Swine flu vaccine: Dangerous or safe?

  • Cara Natterson MD
  • Jay Gordon MD
  • Robert Sears MD

Dec. 7, 2009 - 13 weeks ago

To vaccinate or not to vaccinate?  The debate over the swine flu vaccine wages on with advocates for and proponents against speaking up and speaking out about the safety and effectiveness of the shot.  Our Parents Ask experts share their wide range of opinions to help you make the right decision for your family. 

Watch Now | Join the Discussion

Related Topics: Elementary School

Tags: H1N1 vaccine

You must be logged in to post comments.

Sign Up or Login with Facebook to join the Parents Ask community

Have a Question?

Ask the experts at ParentsAsk.com

How it Works

Quick Poll

Do you think today's kids are over-medicated?

Yes! It seems like there's a pill for everything with little concern for the side effects.
16%
No. I think more kids are being helped by the availability of new medicines.
84%